Initiator Pharma A/S reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was DKK 9.27 million compared to DKK 15.15 million a year ago. Basic loss per share from continuing operations was DKK 0.18 compared to DKK 0.35 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.16 SEK | -1.08% | -0.43% | -0.87% |
23/02 | Initiator Pharma A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
21/02 | Initiator Pharma Issues New Shares for Debt Conversion | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.87% | 45.1M | |
+23.37% | 47.02B | |
+49.51% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- INIT Stock
- News Initiator Pharma A/S
- Initiator Pharma A/S Reports Earnings Results for the First Quarter Ended March 31, 2023